Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05748171
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2023-01-20
Brief Title:
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin InO in Children 1 to 18 Years With First Relapse ALL
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-17
Start Date Type:
ACTUAL
Primary Completion Date:
2028-07-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-07-09
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-20
First Submit QC Date:
February 17 2023
Study First Post Date:
2023-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-17
Last Update Post Date:
2024-06-18
Last Update Post Date Type:
ACTUAL